How nephrotoxic is carboplatin?

by Hardy, J. R., Tan, S., Fryatt, I., Wiltshaw, E.
Published 1990

The clinical correlates of serum CA125 in 169 patients with epithelial ovarian carcinoma.

by Hawkins, R. E., Roberts, K., Wiltshaw, E., Mundy, J., McCready, V. R.
Published 1989

Binding of peanut lectin to germinal-centre cells: a marker for B-cell subsets of follicular lymphoma?

by Rose, M. L., Habeshaw, J. A., Kennedy, R., Sloane, J., Wiltshaw, E., Davies, A. J.
Published 1981

Phase II trial of trimelamol in refractory ovarian cancer.

by Judson, I. R., Calvert, A. H., Gore, M. E., Balmanno, K., Gumbrell, L. A., Perren, T., Wiltshaw, E.
Published 1991

A randomised study of carboplatin vs sequential ifosfamide/carboplatin for patients with FIGO stage III epithelial ovarian carcinoma. The London Gynaecologic Oncology Group.

by Perren, T. J., Wiltshaw, E., Harper, P., Slevin, M., Stein, R., Tan, S., Gore, M., Fryatt, I. J., Blake, P. R.
Published 1993